ENTERAL
NIFUROXAZIDE
Public price
25,70 MAD
Active substance
NIFUROXAZIDE
Laboratory
LAPROPHAN
Reimbursable
What is this medicine?
ENTERAL contains NIFUROXAZIDE. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
NIFUROXAZIDE, SUSPENSION BUVABLE, 0,044, FLACON DE 90 ML
Common uses
General use context: liquid oral form, used according to the situation, age, and available presentation.
Laboratory
LAPROPHAN
Availability note
Reimbursable
Hospital price
16,00 MAD
Strength
0,044
Form
SUSPENSION BUVABLE
Presentation
FLACON DE 90 ML
Commercial status
Retiré du Marché
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: 25,70 MAD
Available presentations and strengths
Medicines with the same active substance
NIFOX
100 MG · BOITE DE 16
10,70 MAD
NIFUROXAZIDE PHARMA
100 MG · BOITE DE 16
10,70 MAD
ROXID
100 MG · BOITE DE 16
10,70 MAD
NIFOX
200 MG · BOITE DE 16
12,10 MAD
NIFOX 200 MG
200 MG · Boîte de 16
12,10 MAD
NIFUROXAZIDE PHARMA
200 MG · BOITE DE 16
12,10 MAD
NIFROZID
200 MG · BOITE DE 16
12,30 MAD
SEPTAZIDE
200 MG · BOITE DE 16
12,60 MAD
DISIAC
200 MG · BOITE DE 16
13,10 MAD
NIFROZID
200 MG · 1 BOITE 16 GELULE
13,20 MAD
SEPTAZIDE
200 MG · 1 BOITE 16 GELULE
13,40 MAD
ANTINAL
200 MG · BOITE DE 14
14,80 MAD